Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines
Thursday, 28 March 2024
Authored Items
Involving Patients in the Value Discussion in Oncology
Robert Osborne
VBCC - September 2014 Vol 5, No 7
in
Value in Oncology
Payment Reform Requires Abandoning the Fee-for-Service Approach
Robert Osborne
VBCC - September 2014 Vol 5, No 7
in
Value in Oncology
Older Patients with AML Live Longer with Azacitidine
Robert Osborne
VBCC - August 2014 Vol 5, No 6
in
EHA 2014
Stopping TKIs Safe after Deep Molecular Response
Robert Osborne
VBCC - August 2014 Vol 5, No 6
in
EHA 2014
Enzalutamide Improves Survival After ADT in Patients with Metastatic CRPC
Robert Osborne
VBCC - June 2014 Vol 5, No 5
in
Prostate Cancer
PSA Trend Analysis May Help Avoid Unnecessary Biopsies
Robert Osborne
VBCC - June 2014 Vol 5, No 5
in
Prostate Cancer
Last modified: July 1, 2014
Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines